Dabur India Q1 Review - Peaked Out Performance: Prabhudas Lilladher
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Prabhudas Lilladher Report
We are increasing Dabur India Ltd.'s FY22/23 earnings per share estimates by 2.3%/3.0% on back of-
strong growth expected in beverages portfolio on a low base and
foods business to clock revenues of Rs 1 billion in FY22.
Management expects growth to moderate from current levels and have guided at double digit revenue growth for FY22 led by mid-single digit growth in healthcare (on a strong base), mid-teens growth in home and personal care and high double digit growth in food and beverage.
We however, believe that long term outlook remains positive given-
innovation led growth strategy,
increasing share in oral care on the back of growth in herbal category,
innovations at low price point in beverages allowing Dabur to leverage its distribution,
cost saving initiatives like project Samruddhi and
focus on increasing rural distribution to 80,000 villages in two years.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.